Frequency n (%) | Alectinib (n = 43) | Ceritinib (n = 22) | ||
---|---|---|---|---|
Any Grade | Grade 3–5 | Any Grade | Grade 3–5 | |
Nausea | 4 (9.3) | 1 (2.3) | 6 (27.3) | 2 (9.1) |
Diarrhea | 2 (4.7) | 0 | 8 (36.4) | 3 (13.6) |
Vomiting | 3 (6.9) | 0 | 4 (18.2) | 1 (4.5) |
Elevation of AST/ALT | 10 (23.3) | 3 (6.9) | 3 (13.6) | 1 (4.5) |
Peripheral edema | 2 (4.7) | 0 | 2 (9.1) | 0 |
Blurred vision | 1 (2.3) | 0 | 0 | 0 |
Myalgia | 5 (11.6) | 1 (2.3) | 0 | 0 |
Dose reduction | 3 (6.9) | 5 (22.7) | ||
Treatment discontinuation | 1 (2.3) | 0 |